|
|
|
|
| Enagic UKONΣ (Kangen Turmeric Sigma)
Kangen Ukon Sigma - A specialized supplement composed of Ukon and 14 additional
antioxidants and ingredients including tocotrienol (from rice ears), and
pinstripe ginger.

The
world's first soft vegan capsule turmeric supplement organically produced with
alkaline water.
Innovative packaging technology incorporating a soft vegan capsule is used to
repel moisture and prevent oxidation. It has a high degree of absorption and
even distribution throughout the body. All of the ingredients are washed,
sterilized and processed with Kangen Water® --a world first.
Made with 100% organic turmeric
harvested in Okinawa, Japan.
Okinawan farmers in Yanbaru, renowned for its cornucopia of natural products and
immensely rich soil, grow 100% organic ukon (turmeric).
Kangen Ukon Sigma is a specialized supplement composed of Ukon and 14 additional
antioxidants and ingredients including tocotrienol (from rice ears), and
pinstripe ginger.
The turmeric factory has been registered as a food facility by the U.S. Food and
Drug Administration.
The production plant of the Kangen Ukon Sigma and Enagic foods became a
registered food facility by the U.S. FDA. (Registration number 18161996856)
The high level of safety, quality control, cleanliness, and operation of the
turmeric factory is affirmed by the FDA's registration.
The plant ensures overall safety, approval of quality products, and surveillance
of the circulation of food and supplies.

|
|
|
|
|
|
DISCLAIMER:
This website is for
educational purposes only. It is not intended as a substitute for
the diagnosis, treatment or advice of a qualified, licensed
professional. This site offers medical data and informs about
alternative medical options. No one should consider that this site
represents the "practice of medicine." This site assumes no
responsibility for how the material herein is used. Please note that
this website is constantly updating its content and, therefore, some
of the information may be dated. Also, be advised that the
statements regarding alternative treatments for cancer have not been
evaluated by the FDA. |
|
|
|
|